Dental Antithrombotic Medication Coordination / 牙科操作抗栓药协调

Definition

Dental antithrombotic medication coordination is the joint assessment of dental bleeding risk and systemic thrombotic risk before extraction or oral surgery, without a patient independently stopping aspirin, another antiplatelet drug or an anticoagulant.

Current Synthesis

VOL.75 treats the medication question as a coordination problem rather than a universal stop-or-continue rule. The dental clinician needs to know the exact drug, why it was prescribed, the planned procedure, expected bleeding, relevant tests or comorbidity and the patient’s broader cardiovascular or cerebrovascular risk. When needed, the prescriber or relevant specialist should be involved.

The asymmetry matters: local bleeding may often be managed, while unplanned interruption can expose a person to the condition the medicine was prescribed to prevent. That does not mean every drug must always be continued unchanged. It means the decision belongs to qualified clinicians using current procedure- and patient-specific guidance.

Key Claims

• Patients should not independently stop antiplatelet or anticoagulant medication before dental treatment.
• Aspirin, clopidogrel, warfarin and newer anticoagulants are not interchangeable and may require different assessment.
• The procedure’s extent and local bleeding-control options must be weighed against the indication for antithrombotic therapy.
• The dental clinician and prescribing clinician may need to coordinate when systemic risk or procedural complexity is significant.
• A general public-education answer cannot substitute for a current medication and medical-history review.

Evidence

• No-self-stop boundary: VOL.75 explicitly advises listeners not to stop aspirin or related medication on their own before extraction.
• Risk coordination: VOL.75 places procedural difficulty, bleeding, systemic status and the prescribing specialist inside the decision.
• Drug distinction: VOL.75 distinguishes antiplatelet drugs from warfarin and newer anticoagulants rather than treating them as one class.

Counterevidence & Qualifications

The source is not a peri-procedural protocol and gives no drug-, dose-, indication-, renal-function-, laboratory-, procedure- or local-guideline-specific instruction. Emergency treatment, complex surgery, combined therapy, recent thrombosis, heart-valve or stent history and other high-risk contexts may require different planning. Any change should be made by the treating clinicians using current guidance.

What Changed

• Created a dental coordination boundary that keeps bleeding and thrombotic risk visible together.
• Distinguished “do not stop independently” from a universal instruction to continue every regimen unchanged.

Related Concepts

• Anticoagulation Self-Medication Boundary / 抗凝自行用药边界 - broader boundary against self-directed clot-related medication changes.
• Medical Risk Management - balances competing procedural and systemic harms.
• Dental Provider Qualification Assessment / 牙医与口腔机构资质判断 - supports treatment within appropriate scope and referral.
• Doctor-Patient Communication - requires accurate disclosure of medicines, indication and history.
• Medication Self-Combination Risk / 药物自行叠加风险 - adjacent safety boundary for unsupervised medication decisions.